Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma

[1]  A. Olivi,et al.  Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article. , 2011, Journal of neurosurgery.

[2]  P. Black,et al.  Scale to predict survival after surgery for recurrent glioblastoma multiforme. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Alfredo Quiñones-Hinojosa,et al.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. , 2010, Journal of neurosurgery.

[4]  Henry Brem,et al.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.

[5]  Susan M. Chang,et al.  Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. , 2008, Journal of neurosurgery.

[6]  Henry Brem,et al.  EXTENT OF SURGICAL RESECTION IS INDEPENDENTLY ASSOCIATED WITH SURVIVAL IN PATIENTS WITH HEMISPHERIC INFILTRATING LOW‐GRADE GLIOMAS , 2008, Neurosurgery.

[7]  Alfredo Quinones-Hinojosa,et al.  Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection , 2008, Journal of Neuro-Oncology.

[8]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[9]  A. Quiñones‐Hinojosa,et al.  The human subventricular zone: A source of new cells and a potential source of brain tumors , 2007, Experimental Neurology.

[10]  M. Papadopoulos,et al.  Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases , 2007, British journal of neurosurgery.

[11]  Z. Ram,et al.  Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.

[12]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[13]  Susan M. Chang,et al.  Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. , 2004, Neuro-oncology.

[14]  Mitchel S. Berger,et al.  Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration , 2004, Nature.

[15]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[16]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[17]  D. Miller,et al.  Microsatellite instability occurs in distinct subtypes of pediatric but not adult central nervous system tumors. , 2001, Cancer research.

[18]  M. Genc,et al.  Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas , 1995, The Lancet.

[20]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[21]  Henry Brem,et al.  Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older Patients , 2010, Annals of Surgical Oncology.

[22]  Elizabeth Eisenhauer,et al.  Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. , 2008, The Lancet. Oncology.

[23]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[24]  S. Piantadosi,et al.  Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. , 1995, Lancet.